Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program (Q46526456)

22 December 2017

title

Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program (English)

1 reference

22 December 2017

author name string

Delia S West

1

1 reference

22 December 2017

T Elaine Prewitt

2

1 reference

22 December 2017

Zoran Bursac

3

1 reference

22 December 2017

Holly C Felix

4

1 reference

22 December 2017

publication date

10 April 2008

1 reference

22 December 2017

published in

Obesity

1 reference

22 December 2017

volume

16

1 reference

22 December 2017

page(s)

1413-1420

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Achieving weight and activity goals among diabetes prevention program lifestyle participants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Diabetes trends in the USA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Prevalence of overweight and obesity in the United States, 1999-2004

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Overweight and obesity: prevalence, consequences, and causes of a growing public health problem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Ethnic comparison of weight loss in the Trial of Nonpharmacologic Interventions in the Elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

NIDDK data repository: a central collection of clinical trial data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Effect of weight loss with lifestyle intervention on risk of diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Motivational interviewing improves weight loss in women with type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

A combined breast health/weight loss intervention for Black women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Weight management using a meal replacement strategy: meta and pooling analysis from six studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

31 March 2020

Identifiers

DOI

10.1038/OBY.2008.224

1 reference

22 December 2017

PubMed ID

18421273

1 reference

22 December 2017